180 related articles for article (PubMed ID: 38659056)
1. Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.
Ouyang Y; Chen Y; Chen K; Tang Z; Shi G; Qu C; Zhang K; Yang H
Hum Genomics; 2024 Apr; 18(1):43. PubMed ID: 38659056
[TBL] [Abstract][Full Text] [Related]
2. Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis.
Li J; Wang F; Li Z; Feng J; Men Y; Han J; Xia J; Zhang C; Han Y; Chen T; Zhao Y; Zhou S; Da Y; Chai G; Hao J
J Transl Med; 2024 Mar; 22(1):302. PubMed ID: 38521921
[TBL] [Abstract][Full Text] [Related]
3. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
4. Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses.
Chen B; Wang L; Pu S; Guo L; Chai N; Sun X; Tang X; Ren Y; He J; Hao N
Sci Rep; 2024 Mar; 14(1):6435. PubMed ID: 38499600
[TBL] [Abstract][Full Text] [Related]
5. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
[TBL] [Abstract][Full Text] [Related]
6. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.
Li X; Shen A; Zhao Y; Xia J
Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754
[TBL] [Abstract][Full Text] [Related]
7. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
Zou M; Shao Z
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
[TBL] [Abstract][Full Text] [Related]
8. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targets for endometriosis: Genome-wide Mendelian randomization and colocalization analyses.
Zeng P; Lu L; Zhang H; Li Y; Tan S; Yu T; Zhou H
Gene; 2024 Jan; 893():147970. PubMed ID: 37931855
[TBL] [Abstract][Full Text] [Related]
10. Genetically predicted effects of physical activity and sedentary behavior on myasthenia gravis: evidence from mendelian randomization study.
Li J; Wang F; Zhang C; Li Z; Gao J; Liu H
BMC Neurol; 2023 Aug; 23(1):299. PubMed ID: 37568096
[TBL] [Abstract][Full Text] [Related]
11. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia Gravis and Ischemic Stroke: A Bidirectional Mendelian Randomization Study.
Liu C; Mao C; Li S; Su Y; Liu H; Wang X; Liu W; Zhao J; Liu X; Xu Y
Curr Neurovasc Res; 2023; 20(2):270-279. PubMed ID: 37403387
[TBL] [Abstract][Full Text] [Related]
13. ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
[TBL] [Abstract][Full Text] [Related]
14. Evidence for genetic causal relationships between gut microbiome, metabolites, and myasthenia gravis: a bidirectional Mendelian randomization study.
Sheng D; Wang S; Li P; Li J; Xiao Z; Lv H; Liu W; Xiao B; Zhou L
Front Immunol; 2023; 14():1279845. PubMed ID: 38179043
[TBL] [Abstract][Full Text] [Related]
15. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
16. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization analyses of known and suspected risk factors and biomarkers for myasthenia gravis overall and by subtypes.
Wang W; Ge W; Feng J; Huang M; Zhang X; Xia J; Wang L; Li C
BMC Neurol; 2024 Jan; 24(1):33. PubMed ID: 38238684
[TBL] [Abstract][Full Text] [Related]
19. Novel Drug Targets for Atrial Fibrillation Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Ning Z; Huang Y; Lu H; Zhou Y; Tu T; Ouyang F; Liu Y; Liu Q
Cardiovasc Drugs Ther; 2023 May; ():. PubMed ID: 37212950
[TBL] [Abstract][Full Text] [Related]
20. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia.
Yin KF; Chen T; Gu XJ; Su WM; Jiang Z; Lu SJ; Cao B; Chi LY; Gao X; Chen YP
J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38644354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
